Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thrombophilia × enoxaparin sodium × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 1 Thrombosis 1 Thrombophilia 1 Thromboembolism 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Pulmonary Embolism 1 Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Digestive System Diseases 1

Interventions

enoxaparin sodium 1 Observation 1 Lead 1 Injections 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06153394 2024-04-23

PRIORITY

Western University, Canada

Phase 3 Not yet recruiting

Digestive System Diseases, Thrombosis, Thrombophilia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡